The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer

Curr Med Sci. 2022 Dec;42(6):1186-1200. doi: 10.1007/s11596-022-2625-1. Epub 2022 Oct 3.

Abstract

Objective: T cell receptor-associated transmembrane adaptor 1 (TRAT1) is one of the hub genes regulating T cell receptors (TCRs). Herein, the roles of TRAT1 in the prognosis and immune microenvironment of non-small cell lung cancer (NSCLC) were investigated.

Methods: The expression and prognosis values of TRAT1 in NSCLC, and the relationship between TRAT1 expression levels and cancer immune cell infiltration was identified via the TIMER, UALCAN, TISIDB, and other databases. The mechanism of TRAT1 in NSCLC was analyzed using gene set enrichment analysis (GSEA).

Results: The expression level of TRAT1 was decreased in NSCLC tissues. Low TRAT1 expression was associated with shorter overall survival of patients with NSCLC and was related to gender, smoking, and tumor grade. TRAT1 was involved in regulating immune response, TCR signaling pathway, PI3K/AKT, and other processes. TRAT1 expression levels were positively correlated with immune cell infiltration in NSCLC.

Conclusion: Down-regulation of TRAT1 expression was associated with an unfavorable prognosis and immune infiltration of NSCLC.

Keywords: T cell receptor-associated transmembrane adaptor 1; T cell receptors; immune infiltration; non-small cell lung cancer; prognosis.

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Down-Regulation
  • Humans
  • Lung Neoplasms* / genetics
  • Phosphatidylinositol 3-Kinases
  • Smoking
  • Tumor Microenvironment / genetics

Substances

  • Phosphatidylinositol 3-Kinases
  • TRAT1 protein, human